Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Kyle Molina

TitleClinical Instructor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-EM MED Clinical

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Krsak M, Morrisette T, Damioli L, Flues B, Liu EW, Zhou AY, Msdi AS, McLeod C, Akundi S, Redell M, Molina KC. Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium? Clin Orthop Relat Res. 2025 Mar 14. PMID: 40106384.
      View in: PubMed
    2. Xiao M, Molina KC, Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Fish LE, Hamer MK, Kwan BM, Mayer DA, Peers JL, Wynia MK, Ginde AA. A Machine Learning Method for Allocating Scarce COVID-19 Monoclonal Antibodies. JAMA Health Forum. 2024 Sep 06; 5(9):e242884. PMID: 39269694.
      View in: PubMed
    3. Scherger SJ, Molina KC, Palestine AG, Pecen PE, Bajrovic V. Cytomegalovirus Retinitis in the Modern Era of Solid Organ Transplantation. Transplant Proc. 2024 Sep; 56(7):1696-1701. PMID: 39147617.
      View in: PubMed
    4. Molina KC, Webb BJ, Kennerley V, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Peers JL, Russell S, Wynia MK, Aggarwal NR, Ginde AA. Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5. BMC Infect Dis. 2024 Aug 08; 24(1):802. PMID: 39118052.
      View in: PubMed
    5. Mueller SW, Molina KC, Blass B, Gibson C, Kohler AD, Krsak M, Wiktor AJ. Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. J Burn Care Res. 2024 05 06; 45(3):808-810. PMID: 38422368.
      View in: PubMed
    6. Jenrette JE, Coronato K, Miller MA, Molina KC, Quinones A, Jacknin G. Response to Pan et?al. Acad Emerg Med. 2024 Jul; 31(7):719-720. PMID: 38644581.
      View in: PubMed
    7. Salam ME, Jeffres M, Molina KC, Miller MA, Huang M, Fish DN. Evaluation of Oral Amoxicillin/Clavulanate for Urinary Tract Infections Caused by Ceftriaxone Non-Susceptible Enterobacterales. Pharmacy (Basel). 2024 Apr 01; 12(2). PMID: 38668086.
      View in: PubMed
    8. Jenrette JE, Coronato K, Miller MA, Molina KC, Quinones A, Jacknin G. Prospective evaluation of single-dose aminoglycosides for treatment of complicated cystitis in the emergency department. Acad Emerg Med. 2024 07; 31(7):649-655. PMID: 38450896.
      View in: PubMed
    9. Wendel SK, Wogu AF, Carlson NE, Beaty L, Bennett TD, Bookman K, Mayer DA, Michael SM, Molina KC, Peers JL, Russell S, Zane RD, Ginde AA. Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID-19. J Am Coll Emerg Physicians Open. 2024 Feb; 5(1):e13116. PMID: 38384380.
      View in: PubMed
    10. Aggarwal NR, Beaty LE, Bennett TD, Fish LE, Jacobs JR, Mayer DA, Molina KC, Peers JL, Richardson DB, Russell S, Varela A, Webb BJ, Wynia MK, Xiao M, Carlson NE, Ginde AA. Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study. Lancet Reg Health Am. 2024 Mar; 31:100693. PMID: 38500962.
      View in: PubMed
    11. Texidor WM, Miller MA, Molina KC, Krsak M, Calvert B, Hart C, Storer M, Fish DN. Oritavancin as sequential therapy for Gram-positive bloodstream infections. BMC Infect Dis. 2024 Jan 24; 24(1):127. PMID: 38267844.
      View in: PubMed
    12. Krsak M, Scherger S, Miller MA, Cobb V, Montague BT, Henao-Mart?nez AF, Molina KC. Substance use disorder-associated infections' treatment with dalbavancin enabling outpatient transition (SUDDEN OUT) - an investigator-initiated single-arm unblinded prospective cohort study. Ther Adv Infect Dis. 2024 Jan-Dec; 11:20499361231223889. PMID: 38249543.
      View in: PubMed
    13. Kunz Coyne AJ, Alosaimy S, Lucas K, Lagnf AM, Morrisette T, Molina KC, DeKerlegand A, Schrack MR, Kang-Birken SL, Hobbs AL, Agee J, Perkins NB, Biagi M, Pierce M, Truong J, Andrade J, Bouchard J, Gore T, King MA, Pullinger BM, Claeys KC, Herbin S, Cosimi R, Tart S, Veve MP, Jones BM, Rojas LM, Feehan AK, Scipione MR, Zhao JJ, Witucki P, Rybak MJ. Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022. Microbiol Spectr. 2024 Jan 11; 12(1):e0235123. PMID: 38018984.
      View in: PubMed
    14. Mueller SW, Blass B, Molina KC, Gibson C, Krsak M, Kohler AD, Deeter L, Stalilonis J, Wiktor AJ. Augmented Renal Function in Burn Patients: Occurrence and Discordance With Commonly Used Methods to Assess Renal Function. J Burn Care Res. 2023 11 02; 44(6):1298-1303. PMID: 37450897.
      View in: PubMed
    15. El Ghali A, Morrisette T, Alosaimy S, Lucas K, Tupayachi-Ortiz MG, Vemula R, Wadle C, Philley JV, Mejia-Chew C, Hamad Y, Stevens RW, Zeuli JD, Webb AJ, Fiske CT, Simonyan A, Cimino CL, Mammadova M, Umana VE, Hasbun R, Butt S, Molina KC, Thomas M, Kaip EA, Bouchard J, Gore TW, Howard C, Cabanilla MG, Holger DJ, Frens JJ, Barger M, Ong A, Cohen KA, Rybak MJ. Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0082423. PMID: 37768312.
      View in: PubMed
    16. Abidi MZ, Molina KC, Garth K, Gutman JA, Weinberg A. Cytomegalovirus Immune reconstitution in cord blood transplant recipients on letermovir prophylaxis. Transpl Infect Dis. 2023 Oct; 25(5):e14104. PMID: 37436771.
      View in: PubMed
    17. Molina KC, Mueller SW, Miller MA, Krsak M. Response to Mahatanan and Kang: It's Complicated. Open Forum Infect Dis. 2023 May; 10(5):ofad210. PMID: 37180593.
      View in: PubMed
    18. Molina KC, Kennerley V, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Peers JL, Russell S, Wynia MK, Aggarwal NR, Ginde AA. Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5. Int J Infect Dis. 2023 Jul; 132:34-39. PMID: 37072054.
      View in: PubMed
    19. Molina KC. Best Practices in the Management of Infectious Complications for Patients With Cancer: Management of Febrile Neutropenia. J Adv Pract Oncol. 2023 Apr; 14(3):201-206. PMID: 37197726.
      View in: PubMed
    20. Molina KC, Ginde AA. Real-world use of nirmatrelvir-ritonavir: who benefits? Lancet Infect Dis. 2023 07; 23(7):765-767. PMID: 36933566.
      View in: PubMed
    21. Vargas Barahona L, Molina KC, Pedraza-Ar?valo LC, Sillau S, Tagawa A, Scherger S, Chastain DB, Shapiro L, Tuells J, Franco-Paredes C, Hawkins KL, Maloney JP, Thompson GR, Henao-Mart?nez AF. Previous corticosteroid exposure associates with an increased Pneumocystis jirovecii pneumonia mortality among HIV-negative patients: a global research network with a follow-up multicenter case-control study. Ther Adv Infect Dis. 2023 Jan-Dec; 10:20499361231159481. PMID: 36938147.
      View in: PubMed
    22. Aggarwal NR, Molina KC, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Peers JL, Russell S, Wynia MK, Ginde AA. Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study. Lancet Infect Dis. 2023 06; 23(6):696-705. PMID: 36780912.
      View in: PubMed
    23. Alosaimy S, Lagnf AM, Hobbs ALV, Mubarez M, Kufel WD, Morrisette T, Polisetty RS, Li D, Veve MP, Simon SP, Truong J, Finch N, Venugopalan V, Rico M, Amaya L, Yost C, Cubillos A, Chandler E, Patch M, Smith IMK, Biagi M, Wrin J, Moore WJ, Molina KC, Rebold N, Holger D, Kunz Coyne AJ, Jorgensen SCJ, Witucki P, Tran NN, Davis SL, Sakoulas G, Rybak MJ. Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam. Clin Infect Dis. 2023 02 08; 76(3):e1444-e1455. PMID: 35982631.
      View in: PubMed
    24. Douin DJ, Wogu AF, Beaty LE, Carlson NE, Bennett TD, Aggarwal NR, Mayer DA, Ong TC, Russell S, Steele J, Peers JL, Molina KC, Wynia MK, Ginde AA. Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients. BMC Infect Dis. 2022 Nov 07; 22(1):818. PMID: 36344927.
      View in: PubMed
    25. Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Molina KC, Peers JL, Russell S, Wynia MK, Ginde AA. Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase. Int J Infect Dis. 2023 Mar; 128:310-317. PMID: 36229005.
      View in: PubMed
    26. Alosaimy S, Morrisette T, Lagnf AM, Rojas LM, King MA, Pullinger BM, Hobbs ALV, Perkins NB, Veve MP, Bouchard J, Gore T, Jones B, Truong J, Andrade J, Huang G, Cosimi R, Kang-Birken SL, Molina KC, Biagi M, Pierce M, Scipione MR, Zhao JJ, Davis SL, Rybak MJ. Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii. Microbiol Spectr. 2022 10 26; 10(5):e0047922. PMID: 36190427.
      View in: PubMed
    27. Molina KC, Lunowa C, Lebin M, Segerstrom Nunez A, Azimi SF, Krsak M, Mueller SW, Miller MA. Comparison of Sequential Dalbavancin With Standard-of-Care Treatment for Staphylococcus aureus Bloodstream Infections. Open Forum Infect Dis. 2022 Jul; 9(7):ofac335. PMID: 35899276.
      View in: PubMed
    28. Morrisette T, Molina KC, Da Silva B, Mueller SW, Damioli L, Krsak M, Miller MA, Fish DN. Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success. Open Forum Infect Dis. 2022 Jun; 9(6):ofac028. PMID: 35615295.
      View in: PubMed
    29. Johnson TM, Molina KC, Howard AH, Schwarz K, Allen L, Huang M, Bajrovic V, Miller MA. Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence. Clin Infect Dis. 2022 05 03; 74(9):1572-1578. PMID: 34665248.
      View in: PubMed
    30. Hoover RK, Krsak M, Molina KC, Shah K, Redell M. Kimyrsa, An Oritavancin-Containing Product: Clinical Study and Review of Properties. Open Forum Infect Dis. 2022 May; 9(5):ofac090. PMID: 35392455.
      View in: PubMed
    31. Molina KC, Bajrovic V, Bonomo RA. Carbapenemase-producing Enterobacterales in solid organ transplantation: Tip of the iceberg? Transpl Infect Dis. 2022 Apr; 24(2):e13780. PMID: 34962337.
      View in: PubMed
    32. Novak AR, Krsak M, Kiser TH, Neumann RT, Cava Prado L, Molina KC, Mueller SW. Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill Patients. Open Forum Infect Dis. 2022 Feb; 9(2):ofab649. PMID: 35111872.
      View in: PubMed
    33. Molina KC, Miller MA, Mueller SW, Van Matre ET, Krsak M, Kiser TH. Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin. Clin Pharmacokinet. 2022 03; 61(3):363-374. PMID: 34931283.
      View in: PubMed
    34. Alosaimy S, Lagnf AM, Morrisette T, Scipione MR, Zhao JJ, Jorgensen SCJ, Mynatt R, Carlson TJ, Jo J, Garey KW, Allen D, DeRonde K, Vega AD, Abbo LM, Venugopalan V, Athans V, Saw S, Claeys KC, Miller M, Molina KC, Veve M, Kufel WD, Amaya L, Yost C, Ortwine J, Davis SL, Rybak MJ. Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa. Open Forum Infect Dis. 2021 Aug; 8(8):ofab371. PMID: 34430671.
      View in: PubMed
    35. Johnson TM, Howard AH, Miller MA, Allen LL, Huang M, Molina KC, Bajrovic V. Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients. Open Forum Infect Dis. 2021 Jul; 8(7):ofab294. PMID: 34262988.
      View in: PubMed
    36. Mueller SW, Kedzior SK, Miller MA, Reynolds PM, Kiser TH, Krsak M, Molina KC. An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections. Expert Opin Pharmacother. 2021 Jul; 22(10):1355-1371. PMID: 33878996.
      View in: PubMed
    37. Johnson TM, Molina KC, Miller MA, Kiser TH, Huang M, Mueller SW. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care. Int J Antimicrob Agents. 2021 Apr; 57(4):106310. PMID: 33609718.
      View in: PubMed
    38. Miller MA, Molina KC, Gutman JA, Scherger S, Lum JM, Mossad SB, Burgess M, Cheng MP, Chuang ST, Jacobs SE, Melendez DP, Shah DP, Zimmer A, Sohail MR, Syed S, Walker RC, Poeschla EM, Abidi MZ. Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents. Open Forum Infect Dis. 2021 Feb; 8(2):ofaa646. PMID: 33575424.
      View in: PubMed
    39. Molina KC, Morrisette T, Miller MA, Huang V, Fish DN. The Emerging Role of ?-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Antimicrob Agents Chemother. 2020 06 23; 64(7). PMID: 32312776.
      View in: PubMed
    40. Krsak M, Morrisette T, Miller M, Molina K, Huang M, Damioli L, Pisney L, Wong M, Poeschla E. Advantages of Outpatient Treatment with Long-Acting Lipoglycopeptides for Serious Gram-Positive Infections: A Review. Pharmacotherapy. 2020 05; 40(5):469-478. PMID: 32239771.
      View in: PubMed
    41. Alosaimy S, Molina KC, Claeys KC, Andrade J, Truong J, King MA, Pullinger BM, Huang G, Morrisette T, Lagnf AM, Davis SL, Rybak MJ. Early Experience With Eravacycline for Complicated Infections. Open Forum Infect Dis. 2020 May; 7(5):ofaa071. PMID: 32411809.
      View in: PubMed
    42. Molina KC, Hall ST, Barletta JF, Mangram AJ, Dzandu JK, Huang V. Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal Clearance. Surg Infect (Larchmt). 2020 Feb; 21(1):43-47. PMID: 31335259.
      View in: PubMed
    43. Molina KC, Barletta JF, Hall ST, Yazdani C, Huang V. The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime. J Intensive Care Med. 2020 Dec; 35(12):1434-1438. PMID: 30741072.
      View in: PubMed
    44. Hall ST, Molina KC. Fixed-dose 4-factor prothrombin complex concentrate: we don't know where we're going if we don't know how to get there. J Thromb Thrombolysis. 2018 Jul; 46(1):50-57. PMID: 29611104.
      View in: PubMed
    45. Molina KC, Fairman KA, Sclar DA. Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits. Drug Healthc Patient Saf. 2018; 10:37-43. PMID: 29760569.
      View in: PubMed
    46. Das BB, Pruitt E, Molina K, Ravekes W, Auerbach S, Savage A, Knox L, Kirklin JK, Naftel DC, Hsu D. The impact of flow PRA on outcome in pediatric heart recipients in modern era: An analysis of the Pediatric Heart Transplant Study database. Pediatr Transplant. 2018 02; 22(1). PMID: 29144053.
      View in: PubMed
    47. Molina KC, Huang V. Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections. Curr Infect Dis Rep. 2016 Dec; 18(12):47. PMID: 27873126.
      View in: PubMed
    Molina's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (126) concept(s)
    _
    Co-Authors Expand Description
    See all (36) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)